买球论坛

Expert forum

首页 买球论坛 标本专家Ligthart STFeatures in Breast, Colorectal and Prostate Cancer.
注册

Ligthart STFeatures in Breast, Colorectal and Prostate Cancer.

2017-12-08 07:51来源:原版作者:Ligthart ST

BACKGROUND:

Presence of circulating tumor cells (CTC) in patients with metastatic breast, colorectal and prostate cancer is indicative for poor prognosis. An automated CTC (aCTC) algorithm developed previously to eliminate the variability in manual counting of CTC (mCTC) was used to extract morphological features. Here we validated the aCTC algorithm on CTC images from prostate, breast and colorectal cancer patients and investigated the role of quantitative morphological parameters.

METHODOLOGY:

Stored images of samples from patients with prostate, breast and colorectal cancer, healthy controls, benign breast and colorectal tumors were obtained using the CellSearch system. Images were analyzed for the presence of aCTC and their morphological parameters measured and correlated with survival.

RESULTS:

Overall survival hazard ratio was not significantly different for aCTC and mCTC. The number of CTC correlated strongest with survival, whereas CTC size, roundness and apoptosis features reached significance in univariate analysis, but not in multivariate analysis. One aCTC/7.5 ml of blood was found in 7 of 204 healthy controls and 9 of 694 benign tumors. In one patient with benign tumor 2 and another 9 aCTC were detected.

SIGNIFICANCE OF THE STUDY:

CTC can be identified and morphological features extracted by an algorithm on images stored by the CellSearch system and strongly correlate with clinical outcome in metastatic breast, colorectal and prostate cancer.

版权声明:

本网站所有注明“来源:“买球APP”的文字、图片和音视频资料,版权均属于买球APP所有,非经授权,任何媒体、网站或个人不得转载,授权转载时须注明

“来源:买球APP”。本网所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与买球网联系,买球网将立即进行删除处理。

网友评论: